Skip to main content
. 2021 May 27;18(13):2789–2798. doi: 10.7150/ijms.58742

Table 3.

Meta-analysis of 18 studies reporting the association between 16 hematological biomarkers and severity of COVID-19 infection

Biomarkers N of Study SMD (95%CI) I2 Chi-square (P-value) Egger test (P-value)
Lymphocyte (×109/L) 9 [21,22,23,25,26.27,28,29,31] 1.48 (1.30; 1.67) 97.0 289.26 (P < 0.001) 0.69 (P = 0.51)
CD3+ T cell (×1012/L) 8 21,23,25,27,28,29,30,33 1.28 (1.09; 1.47) 94 108.54 (P < 0.001) 1.69 (P = 0.23)
Neutrophils (×109/L) 9 21,22,23,25,26,27,28,29,31 -2.06 (-2.26; -1.86) 96 178.38 (P < 0.001) 0.01 (P = 0.99)
PLT (×109/L) 2 23,25,27 0.37 (0.05; 0.69) 0.0 1.81 (P=0.40) 0.09 (P = 0.94)
CD4+ T cell (×1012/L) 8 21,23,25,27,28,29,30,33 2.11 (1.91; 2.31) 82 39.37 (P < 0.001) 2.84 (P = 0.04)
CD8+ T cell (×1012/L) 8 21,23,25,27,28,29,30,33 1.00(0.83; 1.18) 88 58.60 (P < 0.001) 1.82 (P = 0.11)
CRP (mg/L) 9 22,23,24,25,27,28,31,33,35 -0.83 (-1.07; -0.58) 96 226.59 (P < 0.001) 1.2 (P = 0.36)
DD-dimer (μg/mL) 4 23,25,26,28 -1.75 (-1.99; -1.50) 98 122.56 (P < 0.001) 1.37 (P = 0.3)
NK cell (×106/L) 3 21,25,30 21.21 (18.28; 24.15) 56 4.50 (P < 0.001) 0.81 (P = 0.46)
WBC (×109/L) 8 21,22,27,28,29,31,32,36 -1.30 (-.1.54; -1.07) 95 141.24 (P < 0.001) 0.42 (P = 0.05)
FDP (mg/L) 4 27,36,37,38 -1.19 (-1.57; -0.81) 94 52.53 (P < 0.001) 2.02 (P = 0.09)
TT (s) 4 27,36,37,38 0.30 (-0.03; 0.64) 78 13.61 (P < 0.001) 1.06 (P = 0.32)
APTT (s) 4 27,36,37,38 -0.26 (-0.63; 0.10) 94 51.80 (P < 0.001) 0.37 (P = 0.73)
IL-10 (pg/ml) 8 21,23,25,27,28,29,30,31 -1.58 (-1.86; -1.31) 97 221.08 (P < 0.001) 1.66 (P = 0.34)
IL-6 (pg/ml) 15 21,22,23,24,25,26,27,28,29,30,31,32,33,34,35 -6.08 (-6.41; -5.75) 95 298.64 (P < 0.001) 0.91 (P = 0.53)
PDW (%) 4 22,31,37,38 0.43 (0.10; 0.75) 94 47.26 (P < 0.001) 0.67 (P = 0.31)

N: number of studies used. SMD: Standard Mean Difference. I2 was used for quantifying inconsistency: the larger the value, the stronger the heterogeneity.